Suchergebnisse - "Gossec, Laure"

PubPharm (674)

81

Impact of Axial Spondyloarthritis on Quality of Life : Results From the European Map of Axial Spondyloarthritis (EMAS) Study in France

enthalten in: The Journal of rheumatology | 2022

von Kedra, J. | Claudepierre, P. | Flipo, R. | +5

82

Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344

enthalten in: Joint bone spine | 2022

von Wendling, D. | Hecquet, S. | Fogel, O. | +17

ErratumFor: Joint Bone Spine. 2022 May;89(3):105344. - PMID 35038574

83

Improvement in patient-reported outcomes in rheumatoid arthritis patients treated with sarilumab is independent of the cognition levels

enthalten in: Joint bone spine | 2022

von Marotte, H. | Fakra, E. | Flipo, R. | +4

84

Overtreatment in rheumatoid arthritis : are there reasons for concern?

enthalten in: RMD open | 2022

von Ferreira, R. | Gossec, L. | da Silva, J.

CommentOn: RMD Open. 2022 Jan;8(1):. - PMID 35091463

85

Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy : results from the COVID-19 Global Rheumatology Alliance physician-reported registry

enthalten in: RMD open | 2022

von Yeoh, S. | Gianfrancesco, M. | Lawson-Tovey, S. | +40

86

Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease : an observational study

enthalten in: The Lancet. Rheumatology | 2022

von Izadi, Z. | Gianfrancesco, M. | Schmajuk, G. | +158

87

Evaluation of lupus anticoagulant, damage, and remission as predictors of pregnancy complications in systemic lupus erythematosus : the French GR2 study

enthalten in: Rheumatology (Oxford, England) | 2022

von Larosa, M. | Le Guern, V. | Guettrot-Imbert, G. | +120

88

Disease Control with Upadacitinib in Patients with Psoriatic Arthritis : A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials

enthalten in: Rheumatology and therapy | 2022

von Mease, P. | Kavanaugh, A. | Gladman, D. | +8

89

Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Nash, P. | Richette, P. | Gossec, L. | +9

90

Response to : 'Comment on: 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Gossec et al' by Wei et al

enthalten in: Annals of the rheumatic diseases | 2022

von Gossec, L. | Baraliakos, X. | McInnes, I. | +6

CommentOn: Ann Rheum Dis. 2020 Jun;79(6):700-712. - PMID 32434812